Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia

Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity

1998 • 133 citations

The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.

1995 • 116 citations

Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension

1995 • 104 citations

Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs

1995 • 89 citations

Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus

1995 • 88 citations

Plasma endothelin levels in congenital diaphragmatic hernia

1994 • 74 citations

Pulmonary vascular balance in congenital diaphragmatic hernia: Enhanced endothelin-1 gene expression as a possible cause of pulmonary vasoconstriction

1998 • 65 citations

Effective control of refractory pulmonary hypertension after cardiac operations

1997 • 59 citations

The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide

1996 • 35 citations

Effect of Inhaled Nitric Oxide in Endothelin-1-Induced Pulmonary Hypertension

1998 • 8 citations

HEMODYNAMIC EFFECTS OF DIPYRIDAMOLE AND INHALED NITRIC OXIDE IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION. † 228

1996 • 3 citations